scope of this recommendation project to define treatment targets in PMR. "Clinical improvement" was considered as the first treatment goal after the initiation of GCs, and the response criteria used in the 2012 classification criteria study may be considered The most important limitations of this project are the paucity of high quality trials (as mentioned above) and the fact that GRADE is less well developed for the assessment of rare outcomes. Consequently, the QoE for   Supported by research